The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Anthony Vendetti - Maxim Group LLC - Analyst
: So Eric, it sounds like you're very focused on stabilizing the business, which obviously is something that has to be done when you first come in.
And in terms of the Dental business, which still obviously drives the vast majority of the revenue. In this particular environment that we're in
economically and Dental offices, Dental clinics have always been, I think, and just in my experience, very concerned about investing new capital
or buying new equipment. How do you convince them that this is a must-have product? And also if you could talk about the clinics that you're
currently in, is there a target utilization rate or a way to ensure a certain level of utilization of your STA unit?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
NOVEMBER 14, 2025 / 1:30PM, MLSS.A - Q3 2025 Milestone Scientific Inc Earnings Call
Question: Anthony Vendetti - Maxim Group LLC - Analyst
: Yes. No, that's great. So there's an active effort to try to increase the utilization of the Wand within the current installed base as well as getting the
word out. And like you said, there's a huge opportunity because you don't have a lot of penetration at this time, even though it's the vast majority
of your business.
On the Medical side, maybe I know you decided to refocus on the current clinics that are using it and building that base for broader commercialization.
Can you tell us where the company is with that refocused effort and then the plan for broader commercialization? Is that something that's occurring
in this quarter? Or is that more of a 2026 goal?
Question: Anthony Vendetti - Maxim Group LLC - Analyst
: Okay. Great.
And just to be clear, right, so the focus is on the jurisdictions in Texas, Florida and New Jersey, correct?
Question: Anthony Vendetti - Maxim Group LLC - Analyst
: And just -- maybe it's too early to say, but just a little bit on the timing of -- you said you're going to collect that data and work with Medicare and
make sure about reimbursement. But is that a 6- to 12-month process? Or what's at this point in terms of your vision of when broader
commercialization will start? Do you have any clarity on that at this point?
Question: Bruce Jackson - Benchmark Company LLC - Analyst
: I wanted to touch on the tariffs just real quick. Last quarter, you said that from a supply chain perspective, you're pretty well set. You have inventory
in the states and for the international accounts, could ship out of China. Has there been any change to that during this quarter? And then secondly,
with the international customers, are they -- have they changed their purchase behavior because of the current situation?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
NOVEMBER 14, 2025 / 1:30PM, MLSS.A - Q3 2025 Milestone Scientific Inc Earnings Call
Question: Bruce Jackson - Benchmark Company LLC - Analyst
: Okay. Okay. Great.
And then in terms of the United States marketing effort, any thoughts on the sales force or the composition of the sales force? Do you have, for
example, reimbursement specialists on staff? Tell us a little bit about how you're structuring the sales force, thinking about the sales force right
now.
Question: Bruce Jackson - Benchmark Company LLC - Analyst
: Okay. And then last question for me. With your sales, is there a seasonality pattern where the fourth quarter is generally a strong quarter for you?
And as we're looking at the model, should we be thinking about an uptick in revenue for the fourth quarter?
|
